| Year |
Citation |
Score |
| 2024 |
Jin H, Huang X, Pan Q, Ma N, Xie X, Wei Y, Yu F, Wen W, Zhang B, Zhang P, Chen X, Wang J, Liu RY, Lin J, Meng X, ... Lee MH, et al. The EIF3H-HAX1 axis increases RAF-MEK-ERK signaling activity to promote colorectal cancer progression. Nature Communications. 15: 2551. PMID 38514606 DOI: 10.1038/s41467-024-46521-3 |
0.394 |
|
| 2024 |
Li K, Zhang J, Lyu H, Yang J, Wei W, Wang Y, Luo H, Zhang Y, Jiang X, Yi H, Wang M, Zhang C, Wu K, Xiao L, Wen W, ... ... Lee MH, et al. CSN6-SPOP-HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2306827. PMID 38308184 DOI: 10.1002/advs.202306827 |
0.322 |
|
| 2023 |
Pan Q, Yu F, Jin H, Zhang P, Huang X, Peng J, Xie X, Li X, Ma N, Wei Y, Wen W, Zhang J, Zhang B, Yu H, Xiao Y, ... ... Lee MH, et al. eIF3f Mediates SGOC Pathway Reprogramming by Enhancing Deubiquitinating Activity in Colorectal Cancer. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2300759. PMID 37544925 DOI: 10.1002/advs.202300759 |
0.349 |
|
| 2023 |
Yang Z, Zou S, Zhang Y, Zhang J, Zhang P, Xiao L, Xie Y, Meng M, Feng J, Kang L, Lee MH, Fang L. ACTL6A protects gastric cancer cells against ferroptosis through induction of glutathione synthesis. Nature Communications. 14: 4193. PMID 37443154 DOI: 10.1038/s41467-023-39901-8 |
0.366 |
|
| 2023 |
Wu W, Zhao Y, Qin B, Jiang X, Wang C, Hu R, Ma R, Lee MH, Liu H, Li K, Yuan P. Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer. Ebiomedicine. 93: 104650. PMID 37343364 DOI: 10.1016/j.ebiom.2023.104650 |
0.314 |
|
| 2023 |
Wei W, Qin B, Wen W, Zhang B, Luo H, Wang Y, Xu H, Xie X, Liu S, Jiang X, Wang M, Tang Q, Zhang J, Yang R, Fan Z, ... ... Lee MH, et al. FBXW7β loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth. Signal Transduction and Targeted Therapy. 8: 187. PMID 37202390 DOI: 10.1038/s41392-023-01405-8 |
0.329 |
|
| 2023 |
Xu H, Luo H, Zhang J, Li K, Lee MH. Therapeutic potential of anticancer effects in colorectal cancer. Gut Microbes. 15: 2186114. PMID 36941257 DOI: 10.1080/19490976.2023.2186114 |
0.301 |
|
| 2022 |
Zou S, Qin B, Yang Z, Wang W, Zhang J, Zhang Y, Meng M, Feng J, Xie Y, Fang L, Xiao L, Zhang P, Meng X, Choi HH, Wen W, ... ... Lee MH, et al. CSN6 mediates nucleotide metabolism to promote tumor development and chemoresistance in colorectal cancer. Cancer Research. PMID 36512632 DOI: 10.1158/0008-5472.CAN-22-2145 |
0.315 |
|
| 2022 |
Zhang B, Liu Q, Wen W, Gao H, Wei W, Tang A, Qin B, Lyu H, Meng X, Li K, Jin H, Yu F, Pan Q, Lin J, Lee MH. The chromatin remodeler CHD6 promotes colorectal cancer development by regulating TMEM65-mediated mitochondrial dynamics via EGF and Wnt signaling. Cell Discovery. 8: 130. PMID 36473865 DOI: 10.1038/s41421-022-00478-z |
0.377 |
|
| 2022 |
Meng X, Peng J, Xie X, Yu F, Wang W, Pan Q, Jin H, Huang X, Yu H, Li S, Feng D, Liu Q, Fang L, Lee MH. Roles of lncRNA LVBU in regulating urea cycle/polyamine synthesis axis to promote colorectal carcinoma progression. Oncogene. PMID 35906392 DOI: 10.1038/s41388-022-02413-8 |
0.419 |
|
| 2020 |
Choi HH, Zou S, Wu JL, Wang H, Phan L, Li K, Zhang P, Chen D, Liu Q, Qin B, Nguyen TAT, Yeung SJ, Fang L, Lee MH. EGF Relays Signals to COP1 and Facilitates FOXO4 Degradation to Promote Tumorigenesis. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 7: 2000681. PMID 33101846 DOI: 10.1002/advs.202000681 |
0.4 |
|
| 2020 |
Feng HT, Zou S, Chen M, Xiong F, Lee MH, Fang L, Tang BZ. Tuning Push-Pull Electronic Effects of AIEgens to Boost Theranostic Efficacy for Colon Cancer. Journal of the American Chemical Society. PMID 32479068 DOI: 10.1021/jacs.0c02434 |
0.343 |
|
| 2019 |
Li K, Wu JL, Qin B, Fan Z, Tang Q, Lu W, Zhang H, Xing F, Meng M, Zou S, Wei W, Chen H, Cai J, Wang H, Zhang H, ... ... Lee MH, et al. ILF3 is a substrate of SPOP for regulating serine biosynthesis in colorectal cancer. Cell Research. PMID 31772275 DOI: 10.1038/s41422-019-0257-1 |
0.375 |
|
| 2019 |
Li C, Zhang Z, Zhang S, Yan W, Si C, Lee MH, Li Z. Inhibitory Effects of the Extracts of Juglans sigillata Green Husks on the Proliferation, Migration and Survival of KYSE150 and EC9706 Human Esophageal Cancer Cell Lines. Nutrition and Cancer. 1-10. PMID 30633592 DOI: 10.1080/01635581.2018.1557223 |
0.359 |
|
| 2017 |
Lee M, Fang L, Chen B, Choi H, Shin J, Phan L, Yeung S. ID:4003 COP9 signalosome in regulating EGFR oncogenic signals Biomedical Research and Therapy. 4: 5. DOI: 10.15419/Bmrat.V4Is.213 |
0.508 |
|
| 2016 |
Rezaeian AH, Li CF, Wu CY, Zhang X, Delacerda J, You MJ, Han F, Cai Z, Jeong YS, Jin G, Phan L, Chou PC, Lee MH, Hung MC, Sarbassov D, et al. A hypoxia-responsive TRAF6-ATM-H2AX signalling axis promotes HIF1α activation, tumorigenesis and metastasis. Nature Cell Biology. PMID 27918549 DOI: 10.1038/ncb3445 |
0.421 |
|
| 2016 |
Zhao R, Choi BY, Lee MH, Bode AM, Dong Z. Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in Cancer. Ebiomedicine. 8: 30-39. PMID 27428416 DOI: 10.1016/j.ebiom.2016.04.017 |
0.731 |
|
| 2016 |
Kolb R, Phan L, Borcherding N, Liu Y, Yuan F, Janowski AM, Xie Q, Markan KR, Li W, Potthoff MJ, Fuentes-Mattei E, Ellies LG, Knudson M, Lee M, Yeung SJ, et al. Abstract B20: Obesity-induced Nlrc4 inflammasome promotes angiogenesis in breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-B20 |
0.387 |
|
| 2015 |
Gao S, Fang L, Phan LM, Qdaisat A, Yeung SJ, Lee MH. COP9 signalosome subunit 6 (CSN6) regulates E6AP/UBE3A in cervical cancer. Oncotarget. PMID 26318036 |
0.36 |
|
| 2015 |
Phan LM, Fuentes-Mattei E, Wu W, Velazquez-Torres G, Sircar K, Wood CG, Hai T, Jimenez C, Cote GJ, Ozsari L, Hofmann MC, Zheng S, Verhaak R, Pagliaro L, Cortez MA, ... Lee MH, et al. Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma. Cancer Research. PMID 26282167 DOI: 10.1158/0008-5472.Can-14-3707 |
0.345 |
|
| 2015 |
Choi HH, Phan L, Chou PC, Su CH, Yeung SJ, Chen JS, Lee MH. COP1 enhances ubiquitin-mediated degradation of p27Kip1 to promote cancer cell growth. Oncotarget. PMID 26254224 DOI: 10.18632/ONCOTARGET.3821 |
0.525 |
|
| 2015 |
Shin J, Phan L, Chen J, Lu Z, Lee MH. CSN6 positively regulates c-Jun in a MEKK1-dependent manner. Cell Cycle (Georgetown, Tex.). 0. PMID 26237449 DOI: 10.1080/15384101.2015.1078030 |
0.342 |
|
| 2015 |
Phan L, Chou PC, Velazquez-Torres G, Samudio I, Parreno K, Huang Y, Tseng C, Vu T, Gully C, Su CH, Wang E, Chen J, Choi HH, Fuentes-Mattei E, Shin JH, ... ... Lee MH, et al. The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming. Nature Communications. 6: 7530. PMID 26179207 DOI: 10.1038/Ncomms8530 |
0.758 |
|
| 2015 |
Choi HH, Su CH, Fang L, Zhang J, Yeung SC, Lee MH. CSN6 deregulation impairs genome integrity in a COP1-dependent pathway. Oncotarget. 6: 11779-93. PMID 25957415 |
0.402 |
|
| 2015 |
Choi HH, Guma S, Fang L, Phan L, Ivan C, Baggerly K, Sood A, Lee MH. Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axis. Cell Cycle (Georgetown, Tex.). 14: 2265-73. PMID 25945542 DOI: 10.1080/15384101.2015.1046655 |
0.515 |
|
| 2015 |
Fang L, Yang Z, Zhou J, Tung JY, Hsiao CD, Wang L, Deng Y, Wang P, Wang J, Lee MH. Circadian Clock Gene CRY2 Degradation Is Involved in Chemoresistance of Colorectal Cancer. Molecular Cancer Therapeutics. 14: 1476-87. PMID 25855785 DOI: 10.1158/1535-7163.MCT-15-0030 |
0.366 |
|
| 2015 |
Wen K, Wang P, Sung P, Lee M, Wu C. Abstract 5171: EpCAM expression governs tumor growth or distant metastasis of human endometrial cancer: grow or go theory Cancer Research. 75: 5171-5171. DOI: 10.1158/1538-7445.Am2015-5171 |
0.5 |
|
| 2015 |
Sung P, Huang CF, Hsiao M, Wen K, Yen M, Lee M. Abstract 1922: Target mutation comparasion of WGA circulating tumor cell and primary tumor in epithelial ovarian cancer cell line using NGS Cancer Research. 75: 1922-1922. DOI: 10.1158/1538-7445.Am2015-1922 |
0.435 |
|
| 2014 |
Chen J, Shin JH, Zhao R, Phan L, Wang H, Xue Y, Post SM, Ho Choi H, Chen JS, Wang E, Zhou Z, Tseng C, Gully C, Velazquez-Torres G, Fuentes-Mattei E, ... ... Lee MH, et al. CSN6 drives carcinogenesis by positively regulating Myc stability. Nature Communications. 5: 5384. PMID 25395170 DOI: 10.1038/ncomms6384 |
0.681 |
|
| 2014 |
Fuentes-Mattei E, Velazquez-Torres G, Phan L, Zhang F, Chou PC, Shin JH, Choi HH, Chen JS, Zhao R, Chen J, Gully C, Carlock C, Qi Y, Zhang Y, Wu Y, ... ... Lee MH, et al. Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor-positive breast cancer. Journal of the National Cancer Institute. 106. PMID 24957076 DOI: 10.1093/Jnci/Dju158 |
0.689 |
|
| 2014 |
Phan LM, Yeung SC, Lee MH. Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies. Cancer Biology & Medicine. 11: 1-19. PMID 24738035 DOI: 10.7497/j.issn.2095-3941.2014.01.001 |
0.323 |
|
| 2014 |
Ortiz AP, Perez C, Mora E, Santiago D, Sánchez CT, Muñoz C, Soto M, Lee M. Abstract B29: Case-control study of metabolic syndrome and breast cancer in Puerto Rico Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-B29 |
0.368 |
|
| 2014 |
Fuentes-Mattei E, Velazquez-Torres G, Phan L, Zhang F, Chou P, Shin J, Choi H, Chen J, Zhao R, Chen J, Gully C, Carlock C, Qi Y, Zhang Y, Wu Y, ... ... Lee M, et al. Abstract 3927: Obesity induces changes in adipokines profile and activates Akt/mTOR signaling accelerating breast carcinogenesis and tumor growth Cancer Research. 74: 3927-3927. DOI: 10.1158/1538-7445.Am2014-3927 |
0.377 |
|
| 2013 |
Luo Y, Yang C, Ye M, Jin C, Abbruzzese JL, Lee MH, Yeung SC, McKeehan WL. Deficiency of metabolic regulator FGFR4 delays breast cancer progression through systemic and microenvironmental metabolic alterations. Cancer & Metabolism. 1: 21. PMID 24279986 DOI: 10.1186/2049-3002-1-21 |
0.385 |
|
| 2013 |
Zhao R, Yang HY, Shin J, Phan L, Fang L, Che TF, Su CH, Yeung SC, Lee MH. CDK inhibitor p57 (Kip2) is downregulated by Akt during HER2-mediated tumorigenicity. Cell Cycle (Georgetown, Tex.). 12: 935-43. PMID 23421998 DOI: 10.4161/cc.23883 |
0.77 |
|
| 2013 |
Esteva FJ, Moulder SL, Gonzalez-Angulo AM, Ensor J, Murray JL, Green MC, Koenig KB, Lee MH, Hortobagyi GN, Yeung SC. Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 71: 63-72. PMID 23053261 DOI: 10.1007/S00280-012-1977-9 |
0.308 |
|
| 2013 |
Zhao R, Phan L, Su C, Chen B, Yang H, Chen J, Che T, Qiao Y, Zhang J, Yeung SJ, Lee M. Ubiquitination-Mediated p57Kip2 Degradation by CSN5 Confers Cancer Cell Proliferation Cancer Hallmarks. 1: 133-144. DOI: 10.1166/CH.2013.1013 |
0.399 |
|
| 2013 |
Rojas A, Cromheecke J, Lee M, Hung M, Blechacz B. Abstract 2046: TGF-β drives tumor-progression via JAK/STAT3-signaling in advanced HCC. Cancer Research. 73: 2046-2046. DOI: 10.1158/1538-7445.Am2013-2046 |
0.309 |
|
| 2012 |
Chen B, Zhao R, Su CH, Linan M, Tseng C, Phan L, Fang L, Yang HY, Yang H, Wang W, Xu X, Jiang N, Cai S, Jin F, Yeung SC, ... Lee MH, et al. CDK inhibitor p57 (Kip2) is negatively regulated by COP9 signalosome subunit 6. Cell Cycle (Georgetown, Tex.). 11: 4633-41. PMID 23187808 DOI: 10.4161/cc.22887 |
0.757 |
|
| 2012 |
Xue Y, Chen J, Choi HH, Phan L, Chou PC, Zhao R, Yang H, Santiago J, Liu M, Yeung GE, Yeung SC, Lee MH. HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53. Cell Cycle (Georgetown, Tex.). 11: 4181-90. PMID 23095642 DOI: 10.4161/cc.22413 |
0.779 |
|
| 2012 |
Wu CC, Yang TY, Yu CT, Phan L, Ivan C, Sood AK, Hsu SL, Lee MH. p53 negatively regulates Aurora A via both transcriptional and posttranslational regulation. Cell Cycle (Georgetown, Tex.). 11: 3433-42. PMID 22894933 DOI: 10.4161/Cc.21732 |
0.51 |
|
| 2012 |
Gully CP, Velazquez-Torres G, Shin JH, Fuentes-Mattei E, Wang E, Carlock C, Chen J, Rothenberg D, Adams HP, Choi HH, Guma S, Phan L, Chou PC, Su CH, Zhang F, ... ... Lee MH, et al. Aurora B kinase phosphorylates and instigates degradation of p53. Proceedings of the National Academy of Sciences of the United States of America. 109: E1513-22. PMID 22611192 DOI: 10.1073/pnas.1110287109 |
0.509 |
|
| 2012 |
Qu C, Liang Z, Huang J, Zhao R, Su C, Wang S, Wang X, Zhang R, Lee MH, Yang H. MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN. Cell Cycle (Georgetown, Tex.). 11: 785-96. PMID 22374676 DOI: 10.4161/cc.11.4.19228 |
0.613 |
|
| 2012 |
Fuentes-Mattei E, Gully C, Velazquez-Torres G, Shin J, Chen J, Choi HH, Chou P, Adams HP, Phan L, Yang T, Yeung SJ, Lee M. Abstract LB-283: Aurora B binds p53 during both interphase and mitosis, phosphorylates it and promotes its degradation Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-283 |
0.395 |
|
| 2011 |
Lee MH, Zhao R, Phan L, Yeung SC. Roles of COP9 signalosome in cancer. Cell Cycle (Georgetown, Tex.). 10: 3057-66. PMID 21876386 DOI: 10.4161/cc.10.18.17320 |
0.709 |
|
| 2011 |
Choi HH, Gully C, Su CH, Velazquez-Torres G, Chou PC, Tseng C, Zhao R, Phan L, Shaiken T, Chen J, Yeung SC, Lee MH. COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3σ. Oncogene. 30: 4791-801. PMID 21625211 DOI: 10.1038/Onc.2011.192 |
0.774 |
|
| 2011 |
Zhao R, Fuentes-Mattei E, Velazquez-Torres G, Su CH, Chen J, Lee MH, Yeung SC. Exenatide improves glucocorticoid-induced glucose intolerance in mice. Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy. 4: 61-5. PMID 21448323 DOI: 10.2147/DMSO.S15510 |
0.589 |
|
| 2011 |
He XX, Tu S, Lee M, Yeung SJ. Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients Annals of Oncology. 22: 2640-2645. PMID 21415239 DOI: 10.1093/Annonc/Mdr020 |
0.339 |
|
| 2011 |
Zhao R, Yeung SC, Chen J, Iwakuma T, Su CH, Chen B, Qu C, Zhang F, Chen YT, Lin YL, Lee DF, Jin F, Zhu R, Shaikenov T, Sarbassov D, ... ... Lee MH, et al. Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers. The Journal of Clinical Investigation. 121: 851-65. PMID 21317535 DOI: 10.1172/Jci44111 |
0.753 |
|
| 2011 |
Su CH, Zhao R, Zhang F, Qu C, Chen B, Feng YH, Phan L, Chen J, Wang H, Wang H, Yeung SC, Lee MH. 14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability. Cancer Research. 71: 884-94. PMID 21135113 DOI: 10.1158/0008-5472.CAN-10-2518 |
0.763 |
|
| 2011 |
Feng YH, Velazquez-Torres G, Gully C, Chen J, Lee MH, Yeung SC. The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth. Journal of Cellular and Molecular Medicine. 15: 825-36. PMID 20455996 DOI: 10.1111/j.1582-4934.2010.01083.x |
0.368 |
|
| 2010 |
Jin Q, Yuan LX, Boulbes D, Baek JM, Wang YN, Gomez-Cabello D, Hawke DH, Yeung SC, Lee MH, Hortobagyi GN, Hung MC, Esteva FJ. Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells. Breast Cancer Research : Bcr. 12: R96. PMID 21080941 DOI: 10.1186/bcr2777 |
0.367 |
|
| 2010 |
Su CH, Zhao R, Velazquez-Torres G, Chen J, Gully C, Yeung SC, Lee MH. Nuclear export regulation of COP1 by 14-3-3σ in response to DNA damage. Molecular Cancer. 9: 243. PMID 20843328 DOI: 10.1186/1476-4598-9-243 |
0.706 |
|
| 2010 |
Gully CP, Zhang F, Chen J, Yeung JA, Velazquez-Torres G, Wang E, Yeung SC, Lee MH. Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer. Molecular Cancer. 9: 42. PMID 20175926 DOI: 10.1186/1476-4598-9-42 |
0.43 |
|
| 2010 |
Chen J, Kobayashi M, Darmanin S, Qiao Y, Gully C, Zhao R, Kondo S, Wang H, Wang H, Yeung SJ, Lee M. Abstract 457: Hypoxia-mediated upregulation of Pim-1 contributes to tumor survival Cancer Research. 70: 457-457. DOI: 10.1158/1538-7445.Am10-457 |
0.526 |
|
| 2009 |
Li DQ, Ohshiro K, Reddy SD, Pakala SB, Lee MH, Zhang Y, Rayala SK, Kumar R. E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1. Proceedings of the National Academy of Sciences of the United States of America. 106: 17493-8. PMID 19805145 DOI: 10.1073/Pnas.0908027106 |
0.437 |
|
| 2009 |
Chen J, Kobayashi M, Darmanin S, Qiao Y, Gully C, Zhao R, Kondo S, Wang H, Wang H, Yeung SC, Lee MH. Hypoxia-mediated up-regulation of Pim-1 contributes to solid tumor formation. The American Journal of Pathology. 175: 400-11. PMID 19528349 DOI: 10.2353/ajpath.2009.080972 |
0.711 |
|
| 2009 |
Chen J, Kobayashi M, Darmanin S, Qiao Y, Gully C, Zhao R, Yeung SC, Lee MH. Pim-1 plays a pivotal role in hypoxia-induced chemoresistance. Oncogene. 28: 2581-92. PMID 19483729 DOI: 10.1038/onc.2009.124 |
0.676 |
|
| 2009 |
Pan J, Song E, Cheng C, Lee MH, Yeung SC. Farnesyltransferase inhibitors-induced autophagy: alternative mechanisms? Autophagy. 5: 129-31. PMID 19066466 DOI: 10.4161/auto.5.1.7329 |
0.329 |
|
| 2008 |
Pan J, Chen B, Su CH, Zhao R, Xu ZX, Sun L, Lee MH, Yeung SC. Autophagy induced by farnesyltransferase inhibitors in cancer cells. Cancer Biology & Therapy. 7: 1679-84. PMID 18769123 |
0.695 |
|
| 2008 |
Yeung SJ, Pan J, Lee M. Roles of p53, Myc and HIF-1 in Regulating Glycolysis — the Seventh Hallmark of Cancer Cellular and Molecular Life Sciences. 65: 3981-3999. PMID 18766298 DOI: 10.1007/S00018-008-8224-X |
0.544 |
|
| 2008 |
Zhang XC, Chen J, Su CH, Yang HY, Lee MH. Roles for CSN5 in control of p53/MDM2 activities. Journal of Cellular Biochemistry. 103: 1219-30. PMID 17879958 DOI: 10.1002/jcb.21504 |
0.477 |
|
| 2007 |
Yang HY, Wen YY, Lin YI, Pham L, Su CH, Yang H, Chen J, Lee MH. Roles for negative cell regulator 14-3-3sigma in control of MDM2 activities. Oncogene. 26: 7355-62. PMID 17546054 DOI: 10.1038/sj.onc.1210540 |
0.814 |
|
| 2006 |
Le XF, Bedrosian I, Mao W, Murray M, Lu Z, Keyomarsi K, Lee MH, Zhao J, Bast RC. Anti-HER2 antibody trastuzumab inhibits CDK2-mediated NPAT and histone H4 expression via the PI3K pathway. Cell Cycle (Georgetown, Tex.). 5: 1654-61. PMID 16861913 DOI: 10.4161/Cc.5.15.3007 |
0.414 |
|
| 2006 |
Lee MH, Lozano G. Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins. Seminars in Cancer Biology. 16: 225-34. PMID 16697215 DOI: 10.1016/J.Semcancer.2006.03.009 |
0.557 |
|
| 2006 |
Yang H, Wen YY, Zhao R, Lin YL, Fournier K, Yang HY, Qiu Y, Diaz J, Laronga C, Lee MH. DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer. Cancer Research. 66: 3096-105. PMID 16540659 DOI: 10.1158/0008-5472.Can-05-3620 |
0.799 |
|
| 2006 |
Yang H, Zhang Y, Zhao R, Wen YY, Fournier K, Wu HB, Yang HY, Diaz J, Laronga C, Lee MH. Negative cell cycle regulator 14-3-3sigma stabilizes p27 Kip1 by inhibiting the activity of PKB/Akt. Oncogene. 25: 4585-94. PMID 16532026 DOI: 10.1038/Sj.Onc.1209481 |
0.803 |
|
| 2006 |
Yang H, Zhao R, Lee MH. 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma. Molecular Cancer Therapeutics. 5: 253-60. PMID 16505098 DOI: 10.1158/1535-7163.MCT-05-0395 |
0.764 |
|
| 2006 |
Ding Y, Lee JF, Lu H, Lee MH, Yan DH. Interferon-inducible protein IFIXalpha1 functions as a negative regulator of HDM2. Molecular and Cellular Biology. 26: 1979-96. PMID 16479015 DOI: 10.1128/MCB.26.5.1979-1996.2006 |
0.459 |
|
| 2006 |
Yang HY, Yang H, Zhao R, Lee MH. Modified p27 Kip1 is efficient in suppressing HER2-mediated tumorigenicity. Journal of Cellular Biochemistry. 98: 128-38. PMID 16365885 DOI: 10.1002/jcb.20762 |
0.767 |
|
| 2005 |
Yang H, Zhao R, Yang HY, Lee MH. Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity. Oncogene. 24: 1924-35. PMID 15688030 DOI: 10.1038/sj.onc.1208352 |
0.786 |
|
| 2004 |
Zhang Y, Yang HY, Zhang XC, Yang H, Tsai M, Lee MH. Tumor suppressor ARF inhibits HER-2/neu-mediated oncogenic growth. Oncogene. 23: 7132-43. PMID 15273726 DOI: 10.1038/sj.onc.1207918 |
0.529 |
|
| 2003 |
Yang HY, Wen YY, Chen CH, Lozano G, Lee MH. 14-3-3 sigma positively regulates p53 and suppresses tumor growth. Molecular and Cellular Biology. 23: 7096-107. PMID 14517281 DOI: 10.1128/Mcb.23.20.7096-7107.2003 |
0.822 |
|
| 2001 |
Yang HY, Shao R, Hung MC, Lee MH. p27 Kip1 inhibits HER2/neu-mediated cell growth and tumorigenesis Oncogene. 20: 3695-3702. PMID 11439332 DOI: 10.1038/sj.onc.1204472 |
0.544 |
|
| 2001 |
Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nature Cell Biology. 3: 245-52. PMID 11231573 DOI: 10.1038/35060032 |
0.474 |
|
| 2000 |
Yang H, Zhou BP, Hung M, Lee M. Oncogenic signals of HER-2/neu in regulating the stability of the cyclin-dependent kinase inhibitor p27. Journal of Biological Chemistry. 275: 24735-24739. PMID 10859299 DOI: 10.1074/Jbc.C000147200 |
0.603 |
|
| 1994 |
Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massagué J. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 78: 59-66. PMID 8033212 DOI: 10.1016/0092-8674(94)90572-X |
0.348 |
|
| 1994 |
Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee MH, Massague J, Crabtree GR, Roberts JM. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature. 372: 570-3. PMID 7990932 DOI: 10.1038/372570A0 |
0.308 |
|
| 1991 |
Stover CK, De La Cruz VF, Fuerst TR, Burlein JE, Benson LA, Bennett LT, Bansal GP, Young JF, Lee MH, Hatfull GF, Snapper SB, Barletta RG, Jacobs WR, Bloom BR. New use of BCG for recombinant vaccines Nature. 351: 456-460. PMID 1904554 DOI: 10.1038/351456A0 |
0.457 |
|
| Show low-probability matches. |